| 1 | Benralizumab | 1件:  Benralizumab Benralizumab | 1件:  D09874 
                
                    D09874
                
             (Name: Benralizumab) | 1件:  IL5RA IL5RA 💬 | 4件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件:  44 44, 45, 98, 162, 299 | 
| 2 | Biological: Benralizumab, Biological: Placebo to Mepolizumab | 2件:  Benralizumab Benralizumab, Mepolizumab | 2件:  D04923 
                
                    D04923
                
            , 
                
                    D09874
                
             (Name: Benralizumab) | 2件:  IL5 IL5, IL5RA 💬 | 13件:  Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件:  44 44 | 
| 3 | Biological: Mepolizumab, Biological: Placebo to Benralizumab | 2件:  Benralizumab Benralizumab, Mepolizumab | 2件:  D04923 
                
                    D04923
                
            , 
                
                    D09874
                
             (Name: Benralizumab) | 2件:  IL5 IL5, IL5RA 💬 | 13件:  Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件:  44 44 |